Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 3
2010 3
2011 3
2012 7
2013 6
2014 5
2015 6
2016 3
2017 6
2018 6
2019 8
2020 11
2021 13
2022 18
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Chu et al.
Ackerson B, Bruxvoort K, Qian L, Sy LS, Tseng HF. Ackerson B, et al. Among authors: sy ls. J Infect Dis. 2023 Feb 1;227(3):466-467. doi: 10.1093/infdis/jiac310. J Infect Dis. 2023. PMID: 35880546 No abstract available.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Frutos AM, et al. MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):168-174. doi: 10.15585/mmwr.mm7308a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38421935 Free PMC article.
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States.
Tseng HF, Ackerson BK, Sy LS, Tubert JE, Luo Y, Qiu S, Lee GS, Bruxvoort KJ, Ku JH, Florea A, Takhar HS, Bathala R, Zhou CK, Esposito DB, Marks MA, Anderson EJ, Talarico CA, Qian L. Tseng HF, et al. Among authors: sy ls. Nat Commun. 2023 Sep 20;14(1):5851. doi: 10.1038/s41467-023-41537-7. Nat Commun. 2023. PMID: 37730701 Free PMC article.
Risk of herpes zoster following mRNA COVID-19 vaccine administration.
Florea A, Wu J, Qian L, Lewin B, Sy LS, Lin IC, Ku JH, Tseng HF. Florea A, et al. Among authors: sy ls. Expert Rev Vaccines. 2023 Jan-Dec;22(1):643-649. doi: 10.1080/14760584.2023.2232451. Expert Rev Vaccines. 2023. PMID: 37416973 Free article.
Pediatric Vaccination During the COVID-19 Pandemic.
Ackerson BK, Sy LS, Glenn SC, Qian L, Park CH, Riewerts RJ, Jacobsen SJ. Ackerson BK, et al. Among authors: sy ls. Pediatrics. 2021 Jul;148(1):e2020047092. doi: 10.1542/peds.2020-047092. Epub 2021 Apr 15. Pediatrics. 2021. PMID: 33858983
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine.
Ackerson B, Sy LS, Slezak J, Qian L, Reynolds K, Huang R, Solano Z, Towner W, Qiu S, Simmons SR, Jacobsen SJ, Bruxvoort KJ. Ackerson B, et al. Among authors: sy ls. Vaccine. 2023 Jul 5;41(30):4392-4401. doi: 10.1016/j.vaccine.2023.06.004. Epub 2023 Jun 10. Vaccine. 2023. PMID: 37308363 Free article.
106 results